Pfizer (PFE) EPS (2009 - 2026)
Pfizer (PFE) EPS from Jun 28, 2009 to Mar 29, 2026. The TTM Pfizer (PFE) EPS is $2.13. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Pfizer (PFE) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +58.25% |
| 3 Years TTM | -23.23% |
| 5 Years TTM | +19.00% |
| 10 Years TTM | +10.68% |
| All Time TTM | +7.97% |
Annual EPS change of Pfizer (PFE)
| Year | EPS | Change |
|---|---|---|
| 2026 | $0.47 | -65.47% |
| 2025 | $1.37 | -3.56% |
| 2024 | $1.42 | +277.59% |
| 2023 | $0.38 | -93.29% |
| 2022 | $5.59 | +42.56% |
| 2021 | $3.92 | +138.00% |
| 2020 | $1.65 | -42.71% |
| 2019 | $2.88 | +51.51% |
| 2018 | $1.90 | -46.78% |
| 2017 | $3.57 | +201.22% |
| 2016 | $1.18 | +5.14% |
| 2015 | $1.13 | -21.71% |
| 2014 | $1.44 | -55.43% |
| 2013 | $3.23 | +64.96% |
| 2012 | $1.96 | +52.90% |
| 2011 | $1.28 | +24.61% |
| 2010 | $1.03 | -7.37% |
| 2009 | $1.11 | +2.29% |
| 2008 | $1.08 | N/A |
Comparison Pfizer (PFE) five years EPS CAGR with competitors
Pfizer (PFE) five years EPS CAGR is -6.35%.
| Ticker | Name | five years EPS CAGR | Upside |
|---|---|---|---|
| GILD | Gilead Sciences Inc | 98.59% | -1652.19% |
| LLY | Lilly(Eli) & Company | 29.14% | -558.80% |
| NVO | Novo Nordisk | 24.26% | -481.89% |
| AZN | Astrazeneca plc | 17.09% | -369.12% |
| NVS | Novartis AG | 14.96% | -335.52% |
| JNJ | Johnson & Johnson | 11.59% | -282.45% |
| MRK | Merck & Co Inc | 5.37% | -184.58% |
| BMY | Bristol-Myers Squibb Company | 5.08% | -180.01% |
| GSK | GSK Plc | 4.65% | -173.24% |
| AMGN | AMGEN Inc | 3.49% | -155.02% |